181 related articles for article (PubMed ID: 23000537)
1. Chronic anti-murine Aβ immunization preserves odor guided behaviors in an Alzheimer's β-amyloidosis model.
Wesson DW; Morales-Corraliza J; Mazzella MJ; Wilson DA; Mathews PM
Behav Brain Res; 2013 Jan; 237():96-102. PubMed ID: 23000537
[TBL] [Abstract][Full Text] [Related]
2. Immunization targeting a minor plaque constituent clears β-amyloid and rescues behavioral deficits in an Alzheimer's disease mouse model.
Morales-Corraliza J; Schmidt SD; Mazzella MJ; Berger JD; Wilson DA; Wesson DW; Jucker M; Levy E; Nixon RA; Mathews PM
Neurobiol Aging; 2013 Jan; 34(1):137-45. PubMed ID: 22608241
[TBL] [Abstract][Full Text] [Related]
3. Early hyperactivity in lateral entorhinal cortex is associated with elevated levels of AβPP metabolites in the Tg2576 mouse model of Alzheimer's disease.
Xu W; Fitzgerald S; Nixon RA; Levy E; Wilson DA
Exp Neurol; 2015 Feb; 264():82-91. PubMed ID: 25500142
[TBL] [Abstract][Full Text] [Related]
4. Alzheimer's disease amyloid-β pathology in the lens of the eye.
Moncaster JA; Moir RD; Burton MA; Chadwick O; Minaeva O; Alvarez VE; Ericsson M; Clark JI; McKee AC; Tanzi RE; Goldstein LE
Exp Eye Res; 2022 Aug; 221():108974. PubMed ID: 35202705
[TBL] [Abstract][Full Text] [Related]
5. Neutralization of granulocyte macrophage colony-stimulating factor decreases amyloid beta 1-42 and suppresses microglial activity in a transgenic mouse model of Alzheimer's disease.
Manczak M; Mao P; Nakamura K; Bebbington C; Park B; Reddy PH
Hum Mol Genet; 2009 Oct; 18(20):3876-93. PubMed ID: 19617638
[TBL] [Abstract][Full Text] [Related]
6. β-Amyloid, cholinergic transmission, and cerebrovascular system -- a developmental study in a mouse model of Alzheimer's disease.
Kuznetsova E; Schliebs R
Curr Pharm Des; 2013; 19(38):6749-65. PubMed ID: 23530514
[TBL] [Abstract][Full Text] [Related]
7. Lack of P-glycoprotein Results in Impairment of Removal of Beta-Amyloid and Increased Intraparenchymal Cerebral Amyloid Angiopathy after Active Immunization in a Transgenic Mouse Model of Alzheimer's Disease.
Bruckmann S; Brenn A; Grube M; Niedrig K; Holtfreter S; von Bohlen und Halbach O; Groschup M; Keller M; Vogelgesang S
Curr Alzheimer Res; 2017; 14(6):656-667. PubMed ID: 27915995
[TBL] [Abstract][Full Text] [Related]
8. Reduced effectiveness of Abeta1-42 immunization in APP transgenic mice with significant amyloid deposition.
Das P; Murphy MP; Younkin LH; Younkin SG; Golde TE
Neurobiol Aging; 2001; 22(5):721-7. PubMed ID: 11705631
[TBL] [Abstract][Full Text] [Related]
9. Sensory network dysfunction, behavioral impairments, and their reversibility in an Alzheimer's β-amyloidosis mouse model.
Wesson DW; Borkowski AH; Landreth GE; Nixon RA; Levy E; Wilson DA
J Neurosci; 2011 Nov; 31(44):15962-71. PubMed ID: 22049439
[TBL] [Abstract][Full Text] [Related]
10. Pyroglutamate-modified amyloid-β protein demonstrates similar properties in an Alzheimer's disease familial mutant knock-in mouse and Alzheimer's disease brain.
Wu G; Miller RA; Connolly B; Marcus J; Renger J; Savage MJ
Neurodegener Dis; 2014; 14(2):53-66. PubMed ID: 24158021
[TBL] [Abstract][Full Text] [Related]
11. Vascular endothelial growth factor (VEGF) affects processing of amyloid precursor protein and beta-amyloidogenesis in brain slice cultures derived from transgenic Tg2576 mouse brain.
Bürger S; Noack M; Kirazov LP; Kirazov EP; Naydenov CL; Kouznetsova E; Yafai Y; Schliebs R
Int J Dev Neurosci; 2009 Oct; 27(6):517-23. PubMed ID: 19589380
[TBL] [Abstract][Full Text] [Related]
12. Anti-ApoE antibody given after plaque onset decreases Aβ accumulation and improves brain function in a mouse model of Aβ amyloidosis.
Liao F; Hori Y; Hudry E; Bauer AQ; Jiang H; Mahan TE; Lefton KB; Zhang TJ; Dearborn JT; Kim J; Culver JP; Betensky R; Wozniak DF; Hyman BT; Holtzman DM
J Neurosci; 2014 May; 34(21):7281-92. PubMed ID: 24849360
[TBL] [Abstract][Full Text] [Related]
13. Mannan-Abeta28 conjugate prevents Abeta-plaque deposition, but increases microhemorrhages in the brains of vaccinated Tg2576 (APPsw) mice.
Petrushina I; Ghochikyan A; Mkrtichyan M; Mamikonyan G; Movsesyan N; Ajdari R; Vasilevko V; Karapetyan A; Lees A; Agadjanyan MG; Cribbs DH
J Neuroinflammation; 2008 Sep; 5():42. PubMed ID: 18823564
[TBL] [Abstract][Full Text] [Related]
14. Olfactory dysfunction correlates with amyloid-beta burden in an Alzheimer's disease mouse model.
Wesson DW; Levy E; Nixon RA; Wilson DA
J Neurosci; 2010 Jan; 30(2):505-14. PubMed ID: 20071513
[TBL] [Abstract][Full Text] [Related]
15. Transthyretin accelerates vascular Abeta deposition in a mouse model of Alzheimer's disease.
Wati H; Kawarabayashi T; Matsubara E; Kasai A; Hirasawa T; Kubota T; Harigaya Y; Shoji M; Maeda S
Brain Pathol; 2009 Jan; 19(1):48-57. PubMed ID: 18429966
[TBL] [Abstract][Full Text] [Related]
16. Outstanding Phenotypic Differences in the Profile of Amyloid-β between Tg2576 and APPswe/PS1dE9 Transgenic Mouse Models of Alzheimer's Disease.
Allué JA; Sarasa L; Izco M; Pérez-Grijalba V; Fandos N; Pascual-Lucas M; Ogueta S; Pesini P; Sarasa M
J Alzheimers Dis; 2016 May; 53(3):773-85. PubMed ID: 27258422
[TBL] [Abstract][Full Text] [Related]
17. Amyloid-beta immunization effectively reduces amyloid deposition in FcRgamma-/- knock-out mice.
Das P; Howard V; Loosbrock N; Dickson D; Murphy MP; Golde TE
J Neurosci; 2003 Sep; 23(24):8532-8. PubMed ID: 13679422
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic versus neuroinflammatory effects of passive immunization is dependent on Aβ/amyloid burden in a transgenic mouse model of Alzheimer's disease.
Minami SS; Sidahmed E; Aid S; Shimoji M; Niikura T; Mocchetti I; Rebeck GW; Prendergast JS; Dealwis C; Wetzel R; Bosetti F; Matsuoka Y; Hoe HS; Turner RS
J Neuroinflammation; 2010 Sep; 7():57. PubMed ID: 20920207
[TBL] [Abstract][Full Text] [Related]
19. Soluble Conformers of Aβ and Tau Alter Selective Proteins Governing Axonal Transport.
Sherman MA; LaCroix M; Amar F; Larson ME; Forster C; Aguzzi A; Bennett DA; Ramsden M; Lesné SE
J Neurosci; 2016 Sep; 36(37):9647-58. PubMed ID: 27629715
[TBL] [Abstract][Full Text] [Related]
20. Olfactory dysfunction in the APP/PS1 transgenic mouse model of Alzheimer's disease: Morphological evaluations from the nose to the brain.
Yao ZG; Hua F; Zhang HZ; Li YY; Qin YJ
Neuropathology; 2017 Dec; 37(6):485-494. PubMed ID: 28643854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
